Literature DB >> 26722489

A meta-analysis of xeroderma pigmentosum gene D Ls751Gln polymorphism and susceptibility to hepatocellular carcinoma.

Yu Wang1, Yingren Zhao2, Aiyun Zhang3, Juan Ma3, Zhenzhen Wang3, Xu Zhang3.   

Abstract

Hepatocellular carcinoma (HCC) is one of most common malignant tumors worldwide, but with unclear mechanisms. Xeroderma pigmentosum gene D (XPD) is one important DNA damage repair gene and can be involved in protein mutation. Currently little has been known about XPD polymorphism and HCC susceptibility in Chinese people. This study used a meta-analysis approach to comprehensively investigate the correlation between XPD polymorphism and HCC susceptibility in Chinese population, based on previously published literatures. A computer retrieval system was used to collect all case-control studies about XPD Lys751Gln polymorphism and HCC susceptibility. Data in literatures were extracted for meta-analysis. After the primary screening, four independent studies, which were published in 3 English articles and one Chinese article, were recruited in this study. There were 1,717 samples included in all studies. Using Gln/Gln + Lys/Gln, Lys/Lys + Lys/Gln and Lys allels as the reference, HCC disease alleles including Lys/Lys, Gln/Gln and Gln had OR values (95% CI, I(2)) of 1.007 (0.657~4.672, 91%), 3.516 (0.220~20.661, 48%) and 3.225 (0.278~12.326, 84%), respectively. The polymorphism of XPD751 loci is closely correlated with primary HCC. Lys751Gln polymorphism of XPD gene can be used as one susceptibility factor for HCC.

Entities:  

Keywords:  Lys715Gln; Xeroderma pigmentosum gene D; gene polymorphism; hepatocellular carcinoma; meta-analysis

Mesh:

Substances:

Year:  2015        PMID: 26722489      PMCID: PMC4680434     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue.

Authors:  I Jaitovich-Groisman; N Benlimame; B L Slagle; M H Perez; L Alpert; D J Song; N Fotouhi-Ardakani; J Galipeau; M A Alaoui-Jamali
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

2.  Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma.

Authors:  Ming-Lun Yeh; Ching-I Huang; Chung-Feng Huang; Ming-Yen Hsieh; Jee-Fu Huang; Chia-Yen Dai; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Lung Yu; Wan-Long Chuang
Journal:  Kaohsiung J Med Sci       Date:  2014-12-23       Impact factor: 2.744

3.  Hepatocellular carcinoma: current state of the art in diagnosis and treatment.

Authors:  Jordi Bruix; Massimo Colombo
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-08-23       Impact factor: 3.043

4.  Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study.

Authors:  Tao Yuan; Shaoli Deng; Hongming Liu; Menggang Liu; Ping Chen
Journal:  Exp Ther Med       Date:  2012-05-17       Impact factor: 2.447

5.  [Relation of polymorphisms of the XPD and GSTM1 genes with susceptibility to hepatocellular carcinoma in Qinghai Tibetans].

Authors:  Jun-Hui Zhao; Hua Li; Ji Di
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2014-11

Review 6.  Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.

Authors:  Rong Yang; Chong Zhang; Armah Malik; Zhi-Da Shen; Jian Hu; Yi-He Wu
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.

Authors:  Lingyun Li; Muhammad Noman Khan; Qiang Li; Xiangyu Chen; Jing Wei; Bing Wang; Jya-Wei Cheng; John R Gordon; Fang Li
Journal:  Oncol Rep       Date:  2014-12-08       Impact factor: 3.906

8.  [Study on the relationship between hepatocellular carcinoma and the interaction between polymorphisms in DNA repair gene XPD and environmental factors].

Authors:  Xiao-Yun Zeng; Xiao-Qiang Qiu; Long Ji; Hong-Ping Yu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2009-07

Review 9.  Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.

Authors:  Qiliu Peng; Shan Li; Xianjun Lao; Zhiping Chen; Ruolin Li; Xue Qin
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes.

Authors:  Francesca Capone; Eliana Guerriero; Giovanni Colonna; Patrizia Maio; Alessandra Mangia; Raffaele Marfella; Giuseppe Paolisso; Francesco Izzo; Nicoletta Potenza; Luigi Tomeo; Giuseppe Castello; Susan Costantini
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

View more
  1 in total

1.  Contribution of DNA repair xeroderma pigmentosum group D genotypes to pancreatic cancer risk in the Chinese Han population.

Authors:  Dong Yan; Xiao-Hui Liang; Wei Ding; Xin-Jian Xu; Xi-Yan Wang
Journal:  Genet Mol Biol       Date:  2017-12-18       Impact factor: 1.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.